186 related articles for article (PubMed ID: 12154404)
21. The epigenome of testicular germ cell tumors.
Lind GE; Skotheim RI; Lothe RA
APMIS; 2007 Oct; 115(10):1147-60. PubMed ID: 18042148
[TBL] [Abstract][Full Text] [Related]
22. Restriction landmark genomic scanning method and its various applications.
Hayashizaki Y; Hirotsune S; Okazaki Y; Hatada I; Shibata H; Kawai J; Hirose K; Watanabe S; Fushiki S; Wada S
Electrophoresis; 1993 Apr; 14(4):251-8. PubMed ID: 8388788
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide profiling of promoter methylation in human.
Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
[TBL] [Abstract][Full Text] [Related]
24. Correlation between methylation profile of promoter cpg islands of seven metastasis-associated genes and their expression states in six cell lines of liver origin.
Li JL; Fei Q; Yu J; Zhang HY; Wang P; Zhu JD
Ai Zheng; 2004 Sep; 23(9):985-91. PubMed ID: 15363188
[TBL] [Abstract][Full Text] [Related]
25. Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning.
Ohgane J; Aikawa J; Ogura A; Hattori N; Ogawa T; Shiota K
Dev Genet; 1998; 22(2):132-40. PubMed ID: 9581285
[TBL] [Abstract][Full Text] [Related]
26. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
[TBL] [Abstract][Full Text] [Related]
27. Restriction landmark genome scanning.
Okuizumi H; Takamiya T; Okazaki Y; Hayashizaki Y
Methods Mol Biol; 2011; 791():101-12. PubMed ID: 21913074
[TBL] [Abstract][Full Text] [Related]
28. Restriction landmark genome scanning.
Costello JF; Plass C; Cavenee WK
Methods Mol Biol; 2002; 200():53-70. PubMed ID: 11951655
[No Abstract] [Full Text] [Related]
29. DNAinsight: a web based image processing system for large scale RLGS analysis.
Takahashi K; Nakazawa M; Watanabe Y
Genome Inform; 2001; 12():212-21. PubMed ID: 11791240
[TBL] [Abstract][Full Text] [Related]
30. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
31. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
32. Restriction landmark genomic scanning.
Ando Y; Hayashizaki Y
Nat Protoc; 2006; 1(6):2774-83. PubMed ID: 17406534
[TBL] [Abstract][Full Text] [Related]
33. Silencing of bidirectional promoters by DNA methylation in tumorigenesis.
Shu J; Jelinek J; Chang H; Shen L; Qin T; Chung W; Oki Y; Issa JP
Cancer Res; 2006 May; 66(10):5077-84. PubMed ID: 16707430
[TBL] [Abstract][Full Text] [Related]
34. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
35. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
36. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
37. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA.
Kim YS; Yoo HS; Lee KT; Goh SH; Jung JS; Oh SW; Baba M; Yasuda T; Matsubara K; Nagai H
Int J Oncol; 2000 Aug; 17(2):297-308. PubMed ID: 10891539
[TBL] [Abstract][Full Text] [Related]
38. Restriction landmark genomic scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations.
Smiraglia DJ; Kazhiyur-Mannar R; Oakes CC; Wu YZ; Liang P; Ansari T; Su J; Rush LJ; Smith LT; Yu L; Liu C; Dai Z; Chen SS; Wang SH; Costello J; Ioshikhes I; Dawson DW; Hong JS; Teitell MA; Szafranek A; Camoriano M; Song F; Elliott R; Held W; Trasler JM; Plass C; Wenger R
BMC Genomics; 2007 Nov; 8():446. PubMed ID: 18053125
[TBL] [Abstract][Full Text] [Related]
39. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
[TBL] [Abstract][Full Text] [Related]
40. Methyl group acceptance assay for the determination of global DNA methylation levels.
Nephew KP; Balch C; Skalnik DG
Methods Mol Biol; 2009; 507():35-41. PubMed ID: 18987804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
